P3‐172: Apoe E4 Stratification of Alzheimer's Disease Patients Defines Two Distinct Sets of Plasma Metabolomics Markers Related to Lipid or Mitochondrial Metabolism Dysfunction | Zendy

Calero Miguel | Zendy; Calero Olga | Zendy; Rodríguez-Martín Andrés | Zendy; Veiga Sergio | Zendy; Portero Isabel | Zendy; Campos Yolanda | Zendy; López-Alonso Victoria | Zendy; García-Albert Luis | Zendy

Premium

P3‐172: Apoe E4 Stratification of Alzheimer's Disease Patients Defines Two Distinct Sets of Plasma Metabolomics Markers Related to Lipid or Mitochondrial Metabolism Dysfunction

Author(s) -

Calero Miguel,

Calero Olga,

Rodríguez-Martín Andrés,

Veiga Sergio,

Portero Isabel,

Campos Yolanda,

López-Alonso Victoria,

García-Albert Luis

Publication year - 2016

Publication title -

alzheimer's and dementia

Language(s) - Spanish

Resource type - Journals

SCImago Journal Rank - 6.713

H-Index - 118

eISSN - 1552-5279

pISSN - 1552-5260

DOI - 10.1016/j.jalz.2016.06.1832

Subject(s) - apolipoprotein e , medicine , disease , declaration of helsinki , oncology , metabolomics , alzheimer's disease , informed consent , psychology , bioinformatics , clinical psychology , biology , pathology , alternative medicine

Sergio Veiga1, Andrés Rodríguez-Martín1, Olga Calero2 ,Isabel Portero3, Yolanda Campos4, Victoria López-Alonso4, Luís García-Albert4 , Miguel Calero5. (1) Biocross S.L., Valladolid (Spain); (2) CIBERNED and Chronic Disease Programme, Instituto de Salud Carlos III. Madrid, Spain; (3) IMMPULSO. Madrid, Spain (4) Chronic Disease Programme, Instituto de Salud Carlos III. Madrid, Spain; (5) Chronic Disease Programme, CIBERNED, and CIEN Foundation-Queen Sofia Foundation, Instituto de Salud Carlos III. Madrid, Spain

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research